DS biologicals Europe SRL
1.2 FTEDS biologicals Europe reported total assets of 537,835 € at the end of the 2025 financial year (annual accounts filed with the NBB on 17 May 2026), with 1.2 full-time equivalent.
The score of DS biologicals Europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +34 % Total assets +7 % Headcount (avg FTE) +300 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DS biologicals Europe's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 19,037 € | ||||
| Equity | 163,174 € | ||||
| Cash | 42,845 € | ||||
| EBITDA | 73,287 € | ||||
| Total assets | 537,835 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 17 May 2026
- Year ended 30 Sep 2024filed on 03 Apr 2025
- Year ended 30 Sep 2023filed on 30 Apr 2024
- Year ended 30 Sep 2022filed on 11 Apr 2023
- Year ended 30 Sep 2021filed on 28 Mar 2022
DS biologicals Europe's financial analysis
- Solvency30.3%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DS biologicals Europe
DS biologicals Europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0759.590.766
- VAT number
- BE0759590766
- Peppol
- Registered · 0208:0759590766 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Dec 2020
- Registered office
- 9880 Aalter
- Size
- Micro · 1.2 FTE
- Latest accounts
- 2025 · filed on 17 May 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
DS biologicals Europe (SRL) has been based in Aalter since 2020, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 19,037 € and equity of 163,174 €; its revenue is not published. With 1.2 full-time equivalents, it is a micro-enterprise by headcount.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to DS biologicals Europe
Companies in the same business, of comparable size and area, outside its group.
- JEE - CEE International Activities of agents involved in non-specialised wholesale Assenede · balance sheet 483,424 €
- Cirba Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 67,062 €
- Eurosets Benelux Activities of agents involved in non-specialised wholesale Wavre · balance sheet €1.16m
- AlphaCare Wholesale of pharmaceutical and medical goods Grez-Doiceau · balance sheet 559,557 €
- Metra Activities of agents involved in the wholesale of other particular products Diepenbeek · balance sheet 827,884 €
- Loupi Medical Belgium Wholesale of pharmaceutical and medical goods Mont-Saint-Guibert · balance sheet 440,359 €
- Medilor Activities of agents involved in the wholesale of other particular products Ellezelles · balance sheet 884,711 €
- Ortho Supply Activities of agents involved in non-specialised wholesale Ans · balance sheet 190,579 €
Frequently asked questions about DS biologicals Europe
What is the revenue of DS biologicals Europe?
DS biologicals Europe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DS biologicals Europe?
In Belgium, the VAT number is the company number prefixed with BE: BE0759590766 for DS biologicals Europe, if the company is VAT-registered. Its company number (CBE) is 0759.590.766.
Where is the registered office of DS biologicals Europe?
According to the CBE register, the registered office of DS biologicals Europe is in 9880 Aalter.
What is the equity of DS biologicals Europe?
At the close of the 2025 financial year, the equity of DS biologicals Europe amounts to 163,174 €, a solvency of 30.3% of total assets.
How many people work at DS biologicals Europe?
1.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages DS biologicals Europe?
The register lists 1 active mandates at DS biologicals Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DS biologicals Europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →